These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3910215)

  • 1. Preclinical antitumor and toxicologic profile of carboplatin.
    Rose WC; Schurig JE
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-19. PubMed ID: 3910215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies identifying carboplatin as a viable cisplatin alternative.
    Harrap KR
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():21-33. PubMed ID: 3910219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
    Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of platinol analogs using the M5076 murine sarcoma.
    Rose WC
    Anticancer Res; 1986; 6(4):557-62. PubMed ID: 3530116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung tumour growth delay and normal tissue toxicity induced by three cytotoxic platinum drugs.
    van Rongen E; Kal HB; Kuijpers WC; van Berkel AH
    Strahlenther Onkol; 1992 May; 168(5):300-7. PubMed ID: 1598667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation.
    Presnov MA; Konovalova AL
    Arch Geschwulstforsch; 1988; 58(1):43-9. PubMed ID: 3285804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards an assessment of toxicity in the treatment of ovarian cancer.
    Dones L; Wiltshaw E; Birkhead BG; Jackson RR
    Cancer Chemother Pharmacol; 1987; 20(3):213-8. PubMed ID: 3315279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin: a clinical review.
    Yarbro CH
    Semin Oncol Nurs; 1989 May; 5(2 Suppl 1):63-9. PubMed ID: 2657932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin.
    Muggia FM
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):7-13. PubMed ID: 2655099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H; Kubota T; Takahara T; Takeuchi T; Furukawa T; Kase S; Josui K; Kodaira S; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1135-41. PubMed ID: 2053772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.
    Mangioni C; Bolis G; Pecorelli S; Bragman K; Epis A; Favalli G; Gambino A; Landoni F; Presti M; Torri W
    J Natl Cancer Inst; 1989 Oct; 81(19):1464-71. PubMed ID: 2674459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin.
    Dible SE; Siddik ZH; Boxall FE; Harrap KR
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):813-8. PubMed ID: 2820745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum compounds in children with cancer: toxicity and clinical management.
    Ruggiero A; Trombatore G; Triarico S; Arena R; Ferrara P; Scalzone M; Pierri F; Riccardi R
    Anticancer Drugs; 2013 Nov; 24(10):1007-19. PubMed ID: 23962902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of platinum complexes in athymic mice with human tumors].
    Bukharov IK; Osokina LI; Revazova ES; Moroz LV
    Vopr Onkol; 1988; 34(9):1084-7. PubMed ID: 3188435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin: the clinical spectrum to date.
    Canetta R; Rozencweig M; Carter SK
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():125-36. PubMed ID: 3002623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor activity of cisplatin and carboplatin against human tumor xenografts serially transplanted into nude mice--with special reference to gastric carcinomas].
    Shimoyama Y; Kubota T; Inoue S; Kuzuoka M; Ohishi T; Oka S; Kikuyama S; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2682-7. PubMed ID: 3307633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effect of JM-8 (a cisplatin analogue) on testicular cancer cells in vitro and in vivo].
    Hashimura T; Okada K; Yoshida O
    Gan To Kagaku Ryoho; 1985 May; 12(5):1137-42. PubMed ID: 3888118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.